Bone-kidney axis: A potential therapeutic target for diabetic nephropathy.

Yang, Ming; Luo, Shilu; Yang, Jinfei; Chen, Wei; He, Liyu; Liu, Di; Zhao, Li; Wang, Xi

Yang, Ming; Luo, Shilu; Yang, Jinfei; Chen, Wei; He, Liyu; Liu, Di; Zhao, Li; Wang, Xi.

Afiliação

Yang M; Department of Nutrition, Xiangya Hospital, Central South University, Changsha, China.
Luo S; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Yang J; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Chen W; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
He L; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Liu D; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhao L; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Wang X; Department of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

Front Endocrinol (Lausanne) ; 13: 996776, 2022.

Article em En | MEDLINE | ID: mdl-36353239

Assuntos

Diabetes Mellitus; Nefropatias Diabéticas; Humanos; Nefropatias Diabéticas/patologia; Rim; Diabetes Mellitus/patologia

Palavras-chave

FGF23; bone; bone-derived hormone; diabetic nephropathy; lipocalin 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Nefropatias Diabéticas Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google